{"id":8231,"date":"2015-02-10T00:00:00","date_gmt":"2015-02-09T23:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2015\/02\/10\/neix-combacte-magnet-un-projecte-europeu-per-fomentar-el-desenvolupament-dantibiotics-a-europa\/"},"modified":"2020-05-29T17:34:55","modified_gmt":"2020-05-29T15:34:55","slug":"neix-combacte-magnet-un-projecte-europeu-per-fomentar-el-desenvolupament-dantibiotics-a-europa","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2015\/02\/neix-combacte-magnet-un-projecte-europeu-per-fomentar-el-desenvolupament-dantibiotics-a-europa\/","title":{"rendered":"Neix COMBACTE-MAGNET, un projecte europeu per fomentar el desenvolupament d\u2019antibi\u00f2tics a Europa"},"content":{"rendered":"

34 centres de recerca i cinc companyies farmac\u00e8utiques han engegat el projecte COMBACTE-MAGNET emmarcat en el programa de recerca New Drugs 4 Bad Bugs (ND4BB) de la iniciativa europea sobre Medicaments Innovadors (IMI). L\u2019objectiu del projecte \u00e9s fomentar el desenvolupament d\u2019antibi\u00f2tics a Europa a trav\u00e8s d\u2019estudis i activitats relacionats amb la prevenci\u00f3 i el tractament d\u2019infeccions causades per bacteris Gram-negatius resistents a m\u00faltiples f\u00e0rmacs (MDR-GNB). <\/p>\n

La UMC d\u2019Utrecht als Pa\u00efsos Baixos \u00e9s la coordinadora del projecte que compta amb la col\u00b7laboraci\u00f3 de Miquel Pujol del grup de recerca en epidemiologia de les infeccions bacterianes de l\u2019IDIBELL i l\u2019Hospital Universitari de Bellvitge. <\/p>\n

El projecte COMBACTE-MAGNET <\/p>\n

investigar\u00e0 un nou enfocament per a la prevenci\u00f3 de les infeccions respirat\u00f2ries en pacients de la UCI i noves opcions de tractament per als pacients amb infeccions potencialment mortals a causa de MDR-GNB. <\/p>\n

COMBACTE-MAGNET col\u00b7laborar\u00e0 estretament per enfortir encara m\u00e9s les xarxes cl\u00edniques i de laboratori de COMBACTE, el primer projecte dins del programa ND4BB que va comen\u00e7ar al gener de 2013. A m\u00e9s, es crear\u00e0 una col\u00b7laboraci\u00f3 paneuropea (anomenada EPI-Net) dins COMBACTE- MAGNET <\/p>\n

per mapejar i utilitzar els sistemes de vigil\u00e0ncia disponibles a Europa per tal de descriure de manera \u00f2ptima l’epidemiologia de la resist\u00e8ncia als antibi\u00f2tics i les infeccions amb l’assist\u00e8ncia sanit\u00e0ria.<\/p>\n","protected":false},"excerpt":{"rendered":"

34 centres de recerca i cinc companyies farmac\u00e8utiques han engegat el projecte COMBACTE-MAGNET emmarcat en el programa de recerca New Drugs 4 Bad Bugs (ND4BB) de la iniciativa europea sobre Medicaments Innovadors (IMI). L\u2019objectiu del projecte \u00e9s fomentar el desenvolupament d\u2019antibi\u00f2tics a Europa a trav\u00e8s d\u2019estudis i activitats relacionats amb la prevenci\u00f3 i el tractament […]<\/p>\n","protected":false},"author":6,"featured_media":10937,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1,480],"tags":[],"class_list":["post-8231","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sin-categorizar","category-epidemiologia-de-les-infeccions-bacterianes-patogenesis-i-bases-moleculars-de-la-resistencia-al-antimicrobians"],"publishpress_future_action":{"enabled":false,"date":"2024-11-03 23:28:10","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/8231"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=8231"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/8231\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/10937"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=8231"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=8231"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=8231"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}